Watch RPRX. Know when insiders buy.
One email the day a filing lands. Free.
RPRX
Royalty Pharma plc
62.15
−0.10 −0.16%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
35
FLAG · insiders 25, shorts 44
Insiders, 90 days
−$6.3M
net selling · 0 buys, 4 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
3 / 15
tracked funds hold it
Calls on record
0
nobody we score has called it yet
MKT CAP $24.1BP/E 33.1DIV YIELD 1.46%FCF YIELD —REV TTM $2.5B +10.0%NET INCOME $815M −20.4%NET DEBT $8.1B52W 36.41 – 63.96SEC XBRL · TTM TO Invalid Date
Insider trading
−$6.3M
Net, 90 days
0 / 4
Buys / sells, 90 days
0
Distinct buyers
$0
Bought, 90 days
| Traded | Filed | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 5 | Oct 5 | Urist Marshall · EVP, Research & Investments | Sell | 4,126 | $57.10 | $236K |
| Sep 28 | Sep 30 | Urist Marshall · EVP, Research & Investments | Sell | 4,126 | $57.88 | $239K |
| Sep 22 | Sep 24 | Hite Christopher · EVP & Chairman, Partnering | Sell | 3,927 | $58.93 | $231K |
| Sep 22 | Sep 24 | Hite Christopher · EVP & Chairman, Partnering | Sell | 96,073 | $58.51 | $5.6M |
Source: SEC EDGAR Form 4 filings, pulled nightly; open-market purchases and sales only, no option exercises or grants. The tracker, all tickers.